BasserBRCA
@BasserBRCA
@PennCancer's Basser Center for BRCA serves as a unique resource for those affected by BRCA gene mutations to access expert-approved info, news, edu and support
Researchers suspect the reason why ovarian cancer often begins in the fallopian tube has to do with ovulation, shares @ronny_drapkin. Oncologists are trying to dispel the confusion between “tube-tying” and salpingectomy, which can prevent ovarian cancer: spr.ly/60104byFK
Medical oncologist Payal Shah, MD spoke at the annual @MPBGolfClassic golf tournament, where volunteers assembled care packages for breast cancer patients. All proceeds will go directly to @basserbrca research. We are grateful for your support in funding BRCA-related research!


The Pershing Square Foundation—established by Giving Pledge signatory Bill Ackman—announced seven grants totaling $5.25 million in support of #ovariancancer research. Awardees include @ronny_drapkin, MD, PhD, @basserbrca director of Gynecologic Research: spr.ly/60134bH4z
Researchers from @pennvet, @pennmedicine, & @ChildrensPhila showed that modifying mRNA vaccines with a cytokine could make the benefits of vaccines last longer and offer a potential approach for reducing the risk of cancer. @Basserbrca funded this study. spr.ly/60184bHzQ
Ovarian cancer takes too many lives and receives too little attention. We’re investing $5.25M in bold, interdisciplinary science to change that. The Pershing Square Ovarian Cancer Challenge Grant is supporting 7 world-class researchers to drive progress where it’s most urgently…
Congratulations to @ronny_drapkin (@PennOBGYN), recipient of a 2025 @PershingSqFdn Ovarian Cancer Challenge Grant! @Penn_OCRC @PennCancer @BasserBRCA tinyurl.com/yjvvyr4k
For Maggie, volunteering her body to help advance cancer prevention research is an act of love. “I saw other patients talking about their experience with the clinical trial, and why they were doing it, and I realized, ‘I need to do this!’” @PennMedicine spr.ly/601446cF8


Maliha Tayeb, BA, BS, research coordinator in @KMaxwellLab and Heather Symecko, MPH, Basser executive director of administration, showcased their work during the Prevention, Risk Reduction, and Genetics poster session at the 2025 @ascocancer Annual Meeting.


Dr. Susan Domchek is presented with the 2025 @ASCO-American Cancer Society Cancer Prevention Award as a distinguished expert who has made significant contributions to cancer prevention and research. We’re honored to have her at the forefront of cancer prevention research!




Payal Deepak Shah, MD presented her findings during the 'Diving Deeper to Inform Hereditary Cancer Risk and Outcomes' poster session at the 2025 @ASCO Annual Meeting. Her research focused on Pathogenic Germline Variants: Clinical Implications and Knowledge Gaps.

Angela R. Bradbury, MD presented on Genetic Testing Approach in Patients With Metastatic Cancers at the 2025 @ASCO Annual Meeting: spr.ly/601446vIC
Both the type and location of mutations in BRCA2 significantly contribute to variation in breast cancer risk, according @KLNathanson's population-based research. This study's findings will greatly inform risk estimates for women with BRCA2 mutations: spr.ly/601446vpK

Experts shared some of the most talked-about abstracts and discussions from the 2025 @AACR Annual Meeting, including @ronny_drapkin, Director of Gynecologic Cancer Research, on better understanding features of aggressive disease in early precancers: spr.ly/601546QQ3
A recent study from @KMaxwellLab shed light on the genomic differences in metastatic #prostatecancer btwn non-Hispanic Black + non-Hispanic white veterans, revealing survival outcomes are similar when both groups have equal access to care: spr.ly/601246QTO
#ASCO25 @ASCO A phase Ib trial of DNA plasmid vaccine immunotherapy targeting BRCA1/2 mutations shows encouraging safety data. Dr. Susan Domchek w/ an oral presentation on June 2, 11:30 AM CDT, S100a (Abstract 10505). Cancer interception in action! @BasserBRCA @PennCancer…
Delighted and honored to receive this award from @PershingSqFdn. We are very excited to push our work, led by Matt Knarr @Sophisticaveman, on tumor innervation towards novel diagnostics and therapeutics for ovarian cancer. @BasserBRCA @PennCancer @PennMedCSO @OvCaAcademy
Ovarian cancer takes too many lives and receives too little attention. We’re investing $5.25M in bold, interdisciplinary science to change that. The Pershing Square Ovarian Cancer Challenge Grant is supporting 7 world-class researchers to drive progress where it’s most urgently…
At #ASCO25 our @PennCancer @BasserBRCA teams will be sharing updates on CAR T cell therapy for glioblastoma, cancer interception, and much more! @StephenBagleyMD @DrORourke2 @CharuAggarwalMD spr.ly/6011NfSGz
“It takes people volunteering to move research forward. And I’m very, very glad that I was able to be in the position to do that.” Ben Jarvis is 1 of 44 volunteers participating in the @basserbrca clinical trial that aims to stop cancer before it starts: spr.ly/6016NQJfa




Executive Director Susan Domchek, MD & @PennCancer's Director Robert Vonderheide, MD, DPhil at the Fellows of the 2025 @AACR Academy Induction and Opening Ceremonies. Extraordinary scientists 🤝 remarkable work!


Thank you @CharlesIshak from @MDAndersonNews for an inspiring Syndicate talk on repetitive elements and their contribution to tumorigenesis! @BasserBRCA @PennGenomeInteg @ocrahope @ovarcome @TinasWish